Phase II study of brigatinib in patients with tyrosine kinase inhibitor (TKI)-naive ROS1-rearranged advanced non-small cell lung cancer (NSCLC): Barossa cohort 1.
Brigatinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase II study of brigatinib in patients with tyrosine kinase inhibitor (TKI)-naive ROS1-rearranged advanced non-small cell lung cancer (NSCLC): Barossa cohort 1. ### Output: Brigatinib